The healthcare giant has seen its share price dip in recent months, however, a strong earnings report today could boost it back in the right direction.

Looking at the healthcare giant in this instance, from a technical outlook its shares are currently trading at $167.96. Towards the upside, the first resistance level rests at $170.11 followed by a major resistance level at $174.45, which corresponds with the upper red trendline. In the long-term, a break above the major resistance could see J&J's shares hike back up towards its all-time high share price of $187-$188. On the other hand, towards the downside, the first support level sits at $166.48 followed by further support at $157.70 (turquoise trendline). A break below the $157.70 support level could see the stock fall towards the established support base at $155.42 (lower red trendline). Looking at the indicators, MACD is currently negative but heading towards a neutral position and RSI reads 48. Also suggesting a neutral position.